Childhood cardiovascular risk factors and adult cardiovascular events by Jacobs, DR, Woo, JG, Sinaiko, AR, Daniels, SR, Ikonen, J, Juonala, M, Kartiosuo, N, Lehtimäki, T, Magnussen, CG, Viikari, JSA, Zhang, N, Bazzano, LA, Burns, TL, Prineas, RJ, Steinberger, J, Urbina, EM, Venn, AJ, Raitakari, OT, Dwyer, T

“…<p><strong>BACKGROUND:</strong> Childhood cardiovascular risk factors predict subclinical adult cardiovascular disease, but links to clinical events are unclear.…”

Cardiovascular risk scoring for the prevention of cardiovascular disease in low-resource settings by Collins, DRJ

“…<p>The aim of this thesis was to examine the use of total cardiovascular risk scoring for the prevention of cardiovascular disease (CVD) in low-resource settings. …”

PILL AND CARDIOVASCULAR-DISEASE by Beral, V

Predicting cardiovascular disease. by Holt, T

“…<b>An over-abundance of risk models offering few real benefits to patients</b><p> Emerging as a leading cause of death in the early 20th century and peaking in incidence in the 1960s, cardiovascular disease (CVD) remains a major global threat despite a progressively reducing incidence and case fatality for myocardial infarction and stroke. …”

Studies in cardiovascular mechanics by Bertram, C, Bertram, C. D.

The pill and cardiovascular disease. by Beral, V, Kay, C, Vessey, M

Smoking and cardiovascular disease. by Chen, Z, Boreham, J

“…Tobacco, especially cigarette, smoking is a major cause of cardiovascular disease (CVD), responsible for about one third of all CVD deaths in most Western populations. …”

Diabetes and cardiovascular disease. by Neil, A

Cardiovascular disease in Europe. by Rayner, M, Allender, S, Scarborough, P

The Epidemiology of Cardiovascular Disease by Hobbs, R, Hoes, A, Cowie, MR

PILL AND CARDIOVASCULAR-DISEASE by Beral, V, Kay, C, Vessey, M

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. by Hundley, W, Bluemke, D, Bogaert, J, Friedrich, MG, Higgins, C, Lawson, M, McConnell, M, Raman, S, van Rossum, A, Flamm, S, Kramer, C, Nagel, E, Neubauer, S

“…These reporting guidelines are recommended by the Society for Cardiovascular Magnetic Resonance (SCMR) to provide a framework for healthcare delivery systems to disseminate cardiac and vascular imaging findings related to the performance of cardiovascular magnetic resonance (CMR) examinations.…”

Cardiovascular manifestations of Marfan syndrome: insights from advanced cardiovascular magnetic resonance by Pitcher, A

Subjects: “…Cardiovascular disease…”

Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care by Rahimi, K, Lam, C, Steinhubl, S

Maternal smoking and infant cardiovascular physiology: a mechanism of early cardiovascular disease development? by Taylor, L, Kelly, B, Leeson, P

Tetrahydrobiopterin in cardiovascular health and disease. by Bendall, J, Douglas, G, McNeill, E, Channon, K, Crabtree, M

“…We discuss the therapeutic potential of BH4 in cardiovascular disease states and attempt to address how this modulator of intracellular NO-redox balance may ultimately provide a powerful new treatment for many cardiovascular diseases.…”

Cardiovascular magnetic resonance imaging by Karamitsos, T, Neubauer, S

“…CMR also provides important prognostic data for many cardiovascular diseases. CMR is now an essential component of advanced cardiovascular imaging, and it is anticipated that its role will continue to grow in the future. © 2010 Elsevier Ltd. …”

Parathyroid adenomas and cardiovascular risk. by Garcia de la Torre, N, Wass, J, Turner, H

“…Nevertheless, it remains unclear whether patients with untreated mild asymptomatic hyperparathyroidism are at risk for other complications such as increased morbidity and mortality from cardiovascular diseases. There are limited data on the incidence of cardiovascular abnormalities in mild pHPT. …”

Rivaroxaban in stable cardiovascular disease by Cahill, T, Wijesurendra, R, Casadei, B

“…A response to "Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease" N Engl J Med 2017; 377:1319-1330.…”

Niacin for reduction of cardiovascular risk. by Landray, M, Haynes, R, Armitage, J